Immatics (IMTX) Net Cash Flow (2019 - 2025)
Immatics' (IMTX) quarterly Net Cash Flow came in at $13.9 million in Q4 2025, down 67.8% year-on-year from $43.3 million in Q4 2024, and down 84.57% quarter-over-quarter from $90.3 million in Q3 2025.
Immatics (IMTX) Net Cash Flow (2019 - 2025) Analysis & Trends
Immatics has disclosed Net Cash Flow across 7 years of filings, most recently posting $13.9 million for Q4 2025.
- Net Cash Flow for Q4 2025 came in at $13.9 million, down 67.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $144.4 million (up 1437.13% YoY), and the FY2025 annual result was $141.8 million, up 1332.01% from the prior year.
- Net Cash Flow came in at $13.9 million for Q4 2025 at Immatics, down from $90.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $148.3 million in Q4 2023 to a low of -$108.4 million in Q1 2024.
- The 5-year median for Net Cash Flow is $11.5 million (2022), against an average of $8.2 million.
- Across the five-year window, Net Cash Flow slumped 1905.08% in 2022 and jumped 999.38% in 2023, its largest moves.
- Immatics' Net Cash Flow stood at -$31.7 million in 2021, then jumped by 47.92% to -$16.5 million in 2022, then jumped by 999.38% to $148.3 million in 2023, then slumped by 70.84% to $43.3 million in 2024, then slumped by 67.8% to $13.9 million in 2025.
- The last three Net Cash Flow figures came in at $13.9 million (Q4 2025), $90.3 million (Q3 2025), and $27.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 13.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.93 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Sep 30, 2025 | 90.27 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Jun 30, 2025 | 27.69 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Dec 31, 2024 | 43.25 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Sep 30, 2024 | 35.73 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Jun 30, 2024 | 38.81 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Mar 31, 2024 | -108.40 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Dec 31, 2023 | 148.31 Mn |
| Sep 30, 2023 | -55.73 Mn |
| Sep 30, 2023 | -55.73 Mn |